Furthermore, as seen in AT from T2D versus nondiabetic individuals, ZMAT3 expression is increased together with senescence markers in human liver as the disease progresses from NAFLD to NASH (77), indicating that this gene may also be involved in regulating hepatocyte senescence in human NAFLD/NASH. The gene discussed is ZMAT3; the disease is metabolic dysfunction-associated steatohepatitis.